ClinicalTrials.Veeva

Menu

Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital (CAPNIRS)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Extremely Premature Newborn (Born Before 32 Weeks' Gestation)

Treatments

Other: Collection of brain and kidney NIRS measurements
Other: echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT06153771
TERNOY-Carriat 2023

Details and patient eligibility

About

Monitoring patent ductus arteriosus is currently performed using echocardiography, an operator-dependent examination which requires holding the child on their back and which is potentially time-consuming. This test is usually carried out on days 2, 4 and 7 after birth.

NIRS (near-infrared spectroscopy) is a non-invasive method of monitoring tissue oxygen saturation using infrared light.

The aim of the study was to investigate an association between cerebral and renal NIRS data and ductus arteriosus status obtained by echocardiography.

Enrollment

26 patients

Sex

All

Ages

Under 48 hours old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Parent who has agreed to participate in the study
  • Very premature newborn (born before 32 weeks' gestation)
  • Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital
  • Before 48 hours of life

Exclusion criteria

  • Newborn with congenital heart disease
  • Newborn with a congenital renal anomaly
  • Newborn with polymalformative syndrome
  • Newborn with a skin anomaly
  • Newborn with severe circulatory failure unrelated to the ductus arteriosus

Trial design

26 participants in 1 patient group

Extremely premature newborn
Description:
(born before 32 weeks' gestation)
Treatment:
Other: echocardiography
Other: Collection of brain and kidney NIRS measurements

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems